These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


120 related items for PubMed ID: 12492762

  • 1. An evaluation of the Dartmouth Assessment of Lifestyle Inventory and the Leeds Dependence Questionnaire for use among detained psychiatric inpatients.
    Ford P.
    Addiction; 2003 Jan; 98(1):111-8. PubMed ID: 12492762
    [Abstract] [Full Text] [Related]

  • 2. Dartmouth Assessment of Lifestyle Instrument (DALI): a substance use disorder screen for people with severe mental illness.
    Rosenberg SD, Drake RE, Wolford GL, Mueser KT, Oxman TE, Vidaver RM, Carrieri KL, Luckoor R.
    Am J Psychiatry; 1998 Feb; 155(2):232-8. PubMed ID: 9464203
    [Abstract] [Full Text] [Related]

  • 3. Psychometric validation of the Leeds Dependence Questionnaire (LDQ) in a young adult clinical sample.
    Kelly JF, Magill M, Slaymaker V, Kahler C.
    Addict Behav; 2010 Apr; 35(4):331-6. PubMed ID: 20004062
    [Abstract] [Full Text] [Related]

  • 4. Item analysis of the Leeds Dependence Questionnaire in community treatment centers.
    Galecki JM, Sherman MF, Prenoveau JM, Chan KS.
    Psychol Assess; 2016 Sep; 28(9):1061-73. PubMed ID: 27537001
    [Abstract] [Full Text] [Related]

  • 5. Validation of the Kinyarwanda-version Short-Form Leeds Dyspepsia Questionnaire and Short-Form Nepean Dyspepsia Index to assess dyspepsia prevalence and quality-of-life impact in Rwanda.
    Nkurunziza A, Dusabejambo V, Everhart K, Bensen S, Walker T.
    BMJ Open; 2016 Jun 06; 6(6):e011018. PubMed ID: 27266772
    [Abstract] [Full Text] [Related]

  • 6. Development of the Leeds Dependence Questionnaire (LDQ): a questionnaire to measure alcohol and opiate dependence in the context of a treatment evaluation package.
    Raistrick D, Bradshaw J, Tober G, Weiner J, Allison J, Healey C.
    Addiction; 1994 May 06; 89(5):563-72. PubMed ID: 8044122
    [Abstract] [Full Text] [Related]

  • 7. The Drug Abuse Screening Test preserves its excellent psychometric properties in psychiatric patients evaluated in an emergency setting.
    Giguère CÉ, Potvin S, Signature Consortium.
    Addict Behav; 2017 Jan 06; 64():165-170. PubMed ID: 27614056
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Clinician-rated versus self-rated screening for bipolar disorder among inpatients with mood symptoms and substance misuse.
    Goldberg JF, Garakani A, Ackerman SH.
    J Clin Psychiatry; 2012 Dec 06; 73(12):1525-30. PubMed ID: 23290325
    [Abstract] [Full Text] [Related]

  • 11. The Leeds Dyspepsia Questionnaire: a valid tool for measuring the presence and severity of dyspepsia.
    Moayyedi P, Duffett S, Braunholtz D, Mason S, Richards ID, Dowell AC, Axon AT.
    Aliment Pharmacol Ther; 1998 Dec 06; 12(12):1257-62. PubMed ID: 9882035
    [Abstract] [Full Text] [Related]

  • 12. Assessing substance use in multiproblem patients: reliability and validity of the Addiction Severity Index in a mental hospital population.
    Appleby L, Dyson V, Altman E, Luchins DJ.
    J Nerv Ment Dis; 1997 Mar 06; 185(3):159-65. PubMed ID: 9091597
    [Abstract] [Full Text] [Related]

  • 13. Patient experiences questionnaire for interdisciplinary treatment for substance dependence (PEQ-ITSD): reliability and validity following a national survey in Norway.
    Haugum M, Iversen HH, Bjertnaes O, Lindahl AK.
    BMC Psychiatry; 2017 Feb 20; 17(1):73. PubMed ID: 28219361
    [Abstract] [Full Text] [Related]

  • 14. The European Adolescent Assessment Dialogue (EuroADAD): a psychometric evaluation.
    Czobor P, Bácskai E, Oberg D, Haack MJ, Gerevich J.
    Eur Addict Res; 2011 Feb 20; 17(6):302-15. PubMed ID: 21934309
    [Abstract] [Full Text] [Related]

  • 15. Validity and reliability of an Italian version of the revised Leeds disability questionnaire for patients with ankylosing spondylitis.
    Lubrano E, Sarzi Puttini P, Parsons WJ, D'Angelo S, Cimmino MA, Serino F, Pappone N.
    Rheumatology (Oxford); 2005 May 20; 44(5):666-9. PubMed ID: 15757970
    [Abstract] [Full Text] [Related]

  • 16. Psychometric evaluation of the alcohol use disorders identification test and short drug abuse screening test with psychiatric patients in India.
    Carey KB, Carey MP, Chandra PS.
    J Clin Psychiatry; 2003 Jul 20; 64(7):767-74. PubMed ID: 12934976
    [Abstract] [Full Text] [Related]

  • 17. Substance use disorders: Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV) and International Classification of Diseases, tenth edition (ICD-10).
    Hasin D, Hatzenbuehler ML, Keyes K, Ogburn E.
    Addiction; 2006 Sep 20; 101 Suppl 1():59-75. PubMed ID: 16930162
    [Abstract] [Full Text] [Related]

  • 18. Assessing negative consequences in patients with substance use and bipolar disorders: psychometric properties of the short inventory of problems (SIP).
    Bender RE, Griffin ML, Gallop RJ, Weiss RD.
    Am J Addict; 2007 Sep 20; 16(6):503-9. PubMed ID: 18058418
    [Abstract] [Full Text] [Related]

  • 19. Detection of substance use disorders among psychiatric inpatients.
    Lehman AF, Myers CP, Dixon LB, Johnson JL.
    J Nerv Ment Dis; 1996 Apr 20; 184(4):228-33. PubMed ID: 8604032
    [Abstract] [Full Text] [Related]

  • 20. Prevalence and patterns of "dual diagnosis" among psychiatric inpatients.
    Lehman AF, Myers CP, Corty E, Thompson JW.
    Compr Psychiatry; 1994 Apr 20; 35(2):106-12. PubMed ID: 8187473
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.